Jacksonville, Florida
Phase 1 cancer trials in Jacksonville, FL
47 Phase 1 cancer studies are recruiting participants at sites in Jacksonville as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Jacksonville at a glance
- 47 studies are recruiting at a site in Jacksonville.
- By phase: Early Phase 1 (1), Phase 1 (18), Phase 1/2 (28).
- By sponsor: industry (42), university, hospital or other (5).
- By research area: Lung Cancer (16), Breast Cancer (12), Lymphoma (9), Prostate Cancer (5), Pancreatic Cancer (4), Melanoma (1).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in Jacksonville
Basic details from each study's public record (the 30 most recently updated of 47). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- ORIC Pharmaceuticals
- Study site
- Mayo Clinic
- Registry record
- NCT05315700 · updated
Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Cellectar Biosciences, Inc.
- Study site
- Mayo Clinic Florida
- Registry record
- NCT07311993 · updated
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT05877599 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Jacksonville, FL on ClinicalTrials.gov.
Lung cancer studies recruiting in Jacksonville
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- Mayo Clinic Florida
- Registry record
- NCT07277413 · updated
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BlossomHill Therapeutics
- Study site
- Mayo Clinic - Florida
- Registry record
- NCT06706076 · updated
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kumquat Biosciences Inc.
- Study site
- Mayo Clinic, Jacksonville
- Registry record
- NCT06720987 · updated
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Synthekine
- Study site
- Mayo Jacksonville
- Registry record
- NCT05098132 · updated
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT06996782 · updated
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- Mayo Clinic Hospital Jacksonville /ID# 275073
- Registry record
- NCT06772623 · updated
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Tango Therapeutics, Inc.
- Study site
- Mayo Clinic Jacksonville
- Registry record
- NCT06922591 · updated
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Tango Therapeutics, Inc.
- Study site
- Mayo Clinic Jacksonville
- Registry record
- NCT06810544 · updated
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kura Oncology, Inc.
- Study site
- Mayo Clinic Comprehensive Cancer Center
- Registry record
- NCT06026410 · updated
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study site
- Exelixis Clinical Site #78
- Registry record
- NCT05176483 · updated
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Daiichi Sankyo
- Study site
- Mayo Clinic-Jacksonville
- Registry record
- NCT06362252 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Jacksonville, FL on ClinicalTrials.gov.
Prostate cancer studies recruiting in Jacksonville
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Regeneron Pharmaceuticals
- Study site
- Mayo Clinic Jacksonville
- Registry record
- NCT03972657 · updated
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Phase 1
- Ages 18 to 100
- Male participants
- Sponsor
- Janux Therapeutics
- Study site
- Mayo Clinic
- Registry record
- NCT05519449 · updated
Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
- Early Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic in Florida
- Registry record
- NCT05045066 · updated
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- Novartis Pharmaceuticals
- Study site
- Sarah Cannon Research Institute
- Registry record
- NCT07206056 · updated
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Parabilis Medicines, Inc.
- Study site
- Mayo Clinic
- Registry record
- NCT05919264 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Jacksonville, FL on ClinicalTrials.gov.
Melanoma studies recruiting in Jacksonville
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
- Phase 1/2
- Ages 18 to 90
- All sexes
- Sponsor
- Perspective Therapeutics
- Study site
- Mayo Clinic
- Registry record
- NCT05655312 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Jacksonville, FL on ClinicalTrials.gov.
Lymphoma studies recruiting in Jacksonville
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study site
- Nemours Children's Clinic-Jacksonville
- Registry record
- NCT04726241 · updated
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT07123454 · updated
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- Phase 1/2
- Ages 13 to 90
- All sexes
- Sponsor
- Vironexis Biotherapeutics Inc.
- Study site
- Mayo Clinic, Clinical Trials Referral Office
- Registry record
- NCT06533579 · updated
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Ascentage Pharma Group Inc.
- Study site
- Mayo Clinic
- Registry record
- NCT07424833 · updated
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Curis, Inc.
- Study site
- Mayo Clinic
- Registry record
- NCT03328078 · updated
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BeOne Medicines
- Study site
- Mayo Clinic Jacksonville
- Registry record
- NCT05006716 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Jacksonville, FL on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Jacksonville
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- RayzeBio, Inc.
- Registry record
- NCT07165132 · updated
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Artios Pharma Ltd
- Study site
- Mayo Clinic (Florida)
- Registry record
- NCT04657068 · updated
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT06005493 · updated
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Mayo Clinic Cancer Center
- Registry record
- NCT06445062 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Jacksonville, FL on ClinicalTrials.gov.
Ask about studies near Jacksonville
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Florida
All Florida locations
240 studies recruiting across 42 cities.
Tampa
74 studies recruiting.
Miami
47 studies recruiting.
Sarasota
45 studies recruiting.
Orlando
41 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections